retatrutide nejm 2023 obesity trial ly3437943 phase 2 results Weight loss with as compared to licenced Retatrutide study sees significant weight – Retatrutide Weight Loss Results |

This pharmacological advantage could prove decisive in the real-world adherence battle

Effects of L-carnitine supplementation on the quality of life in diabetic patients with muscle cramps.Endocrine journal, EJ17-0431.

Arslan S, Akdevelioglu Y

Ghanizadeh A, Akhondzadeh S, Hormozi M, Makarem A, Abotorabi-Zarchi M, Firoozabadi A

Two GLP-1 Strategies Helped Lock in Weight Loss The new studies, published in peer-reviewed medical journals within a day of each other, were funded by Eli Lilly, which makes the GLP-1 medications Zepbound (tirzepatide) and the oral drug Foundayo (orforglipron)

Some users, particularly those with lighter hair or red hair, report subtle changes in hair pigmentation after prolonged use